Stimulation of CD40 on APCs is through CD40L expression on helper CD4+ T cells which can activate and “license” the APCs to prime CD8+ T cell responses [59,60], and lead to enhanced tumor protection [61,62]. This evidence concerns the gene CD8A and neoplasm.